Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
Source: ClinicalTrials.gov NCT00691600 ↗No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Abscess Resolution |
11; 9 | — |
| SECONDARY Number of Participants Requiring Admission for Failure of Abscess Resolution |
0; 0 | — |
| SECONDARY Number of Participants Requiring New or Modified Antibiotics for Failure of Abscess to Resolve |
1; 2 | — |
Eligibility Criteria
Inclusion Criteria
1.) Abscess 90 days and 10 days), etc.
- Previously failed 48 hours or greater therapy on any antibiotic regimen 6.) Drug allergy to TMP/SMX
7.) Fever > or = 102.2 degrees Fahrenheit in the previous 24 hours 8.) Systemic symptoms on presentation - i.e., nausea , vomiting, persistent tachycardia, hypotension, diaphoresis, etc.
9.) Signs /symptoms of another infection or illness - i.e., influenza, croup, etc.
Data sourced from ClinicalTrials.gov (NCT00691600). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.